ELV240719C690000
- 0.05
- 0.000.00%
Elevance Health Newsroom
Medicare Advantage Linked to Fattest Gross Profits in Insurance: Report
Tame Volatility With These 3 Low Beta Stocks
An Online Pharmacy Pledged to Make Prescriptions Easier. It Sent the Wrong Drugs Instead. -- WSJ
By Kayla Yup | Photographs by Andrew Spear for WSJ Constance Nicastro-Bowman lost hope that her father's medications would ever arrive. Ralph Nicastro, 78 years old, takes 12 prescription drugs a da
Is Elevance Health, Inc. (NYSE:ELV) the Best Health Insurance Stock to Buy Now?
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report
Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2024 Results on July 17, 2024
Elevance Health (NYSE:ELV) will release second quarter 2024 financial results on July 17, 2024, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call
Investing in Elevance Health (NYSE:ELV) Five Years Ago Would Have Delivered You a 103% Gain
Elevance Health Insiders Sell US$9.2m Of Stock, Possibly Signalling Caution
The fact that multiple Elevance Health, Inc. (NYSE:ELV) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. Knowing whether insid
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Morgan Stanley Says Elevance Health's Growth Attributed To Consistent Performance But Undervalued
Morgan Stanley has initiated coverage on Elevance Health Inc (NYSE:ELV), an American health insurance provider formerly Anthem Inc, citing compelling risk-reward.Related: Elevance Health Clocks $2.2B
16 Analysts Have This To Say About Elevance Health
Elevance Health (NYSE:ELV) has been analyzed by 16 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The following table encapsulates their recent ra
Elevance Health Initiated at Overweight by Morgan Stanley
Elevance Health Initiated at Overweight by Morgan Stanley
Elevance Health Price Target Announced at $643.00/Share by Morgan Stanley
Elevance Health Price Target Announced at $643.00/Share by Morgan Stanley
Elevance Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/24/2024 20.32% Morgan Stanley → $643 Initiates Coverage On → Overweight 06/12/2024 12.27% Cantor Fitzge
Morgan Stanley Initiates Elevance Health(ELV.US) With Buy Rating, Announces Target Price $643
Morgan Stanley analyst Erin Wright initiates coverage on $Elevance Health(ELV.US)$ with a buy rating, and sets the target price at $643.According to TipRanks data, the analyst has a success rate of 66
Elevance Health (ELV) Rallies 11.8% YTD: More Room to Run?
Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 10 Years
Elevance Health (NYSE:ELV) has outperformed the market over the past 10 years by 6.3% on an annualized basis producing an average annual return of 17.18%. Currently, Elevance Health has a market capit
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.
Elevance Health, Inc. (ELV): A Feminist Stock That Benefits From Health Care Growth
Elevance Health Insiders Sold US$9.2m Of Shares Suggesting Hesitancy